Neck Management in Head & Neck Cancer

Hi Team,

We just closed out three weeks of oral cavity, so this week we zoom out to management of the neck as a whole before we shift into microvascular reconstruction later in September. As always, we're meeting Wednesday mornings @ 7AM sharp, Munchkins for those who can join in person (working on more healthy options...). If Wednesday doesn't work, email me or grab any of our head and neck surgeons while you're in the OR.

This week's topic is the global framework for neck management: nomenclature, drainage patterns, and the sites where the decision to dissect (or not) is genuinely contested. We already went deep on oral cavity neck management two weeks ago, so consider this the connective tissue that gives the subsite-specific discussions later in the year (oropharynx, larynx, cutaneous) more context, especially for the PGY1s and PGY2s. It's also a good excuse to touch on nodal basins that don't fit neatly into any one month, like the retropharyngeal nodes that oropharyngeal and thyroid cancer both drain to.

Nomenclature First - The Invention of the Neck Dissection (Cannady's Favorite Topic)

Every selective neck dissection we perform traces back to Crile's 1906 description of the radical neck dissection and a century of refinement toward something less morbid, not unlike the path from Halstead's radical mastectomy to lumpectomy in breast surgery. That refinement happened in three documented steps. Robbins Arch Otolaryngol Head Neck Surg 1991 is the first official attempt at shared language, "Standardizing Neck Dissection Terminology," written by the Academy's Committee for Head and Neck Surgery and Oncology and introducing the level I to V system most of us still sketch on a napkin. Robbins Arch Otolaryngol Head Neck Surg 2002 is the AHNS/AAO-HNS joint update that gave us level VI and the IIa/IIb subdivision. Robbins Arch Otolaryngol Head Neck Surg 2008 is the international consensus statement that split level V into Va/Vb and replaced older eponyms like "supraomohyoid" with the level-based shorthand we use today (SND I-III, for example). Head and neck surgery itself was a house divided for most of the 20th century, with general surgeons in the Society of Head and Neck Surgeons and otolaryngologists in the American Society for Head and Neck Surgery running competing meetings until the two merged into the American Head and Neck Society in 1998, with K. Thomas Robbins himself, the same Robbins behind all three classification papers, as a founding co-president.

The Unknown Primary Neck

A squamous cell carcinoma presenting as a neck mass with no obvious primary is really two different clinical problems wearing the same disguise. If the node is p16+/HPV+, you're very likely dealing with an oropharyngeal primary hiding in a tonsil or base of tongue crypt, which triggers the full unknown primary workup we'll cover in detail when we get to the oropharynx (TORS lingual tonsillectomy and base of tongue mucosectomy, built on Mehta Laryngoscope 2013 out of Pittsburgh and refined more recently in our own group's Gobillot Laryngoscope 2025 cohort, using the transoral robotic platform developed here at Penn by Weinstein and O'Malley). If the node is p16-negative and sits in a parotid or upper cervical distribution with a history that fits, you're more likely dealing with an occult cutaneous SCCa, which points toward a posterolateral neck dissection instead of a search for a mucosal primary. The genuinely hard part is that this isn't always clean. A p16-negative node doesn't rule out a non-HPV mucosal primary, an occult cutaneous primary can stay hidden on exam and imaging, and a patient can carry both a remote skin cancer history and a new mucosal lesion competing for your attention at the same visit. How do you decide how hard to keep looking before you commit to a treatment plan built on your best guess?

Occult Disease in the Salvage Neck

Birkeland Otolaryngol Head Neck Surg 2016 looked at occult nodal disease in patients undergoing salvage total laryngectomy after failed radiation or chemoradiation and found a rate around 20%, concentrated in the central neck for glottic recurrences and more common with large supraglottic recurrences. Gross JAMA Otolaryngol Head Neck Surg 2022 is a more recent 107-patient cohort out of Emory that refines this: overall occult rate 16% in clinically node-negative salvage laryngectomy, breaking down to roughly 14% for glottic, 20% for supraglottic, and 17% for hypopharyngeal recurrences, with positive nodes concentrated in levels II and III. The twist is that elective neck dissection in this series wasn't associated with a clinically meaningful survival benefit, even though it was finding real disease at a meaningful rate. How do you justify a procedure that reliably finds cancer but doesn't move overall survival, and where does that leave supraglottic or T3-4 recurrences where the occult rate climbs toward 20%? Practically, we often just do the neck for vessel exposure for free flaps, but it begs the question of the value of bilateral necks when there may be elevated peri-op risk in specific patients.

Cutaneous Metastases - The Parotid Is Part of the Neck

Vauterin Head Neck 2006 mapped drainage patterns for cutaneous SCCa of the head and neck and is the basis for our practice of a supraomohyoid neck dissection with parotid metastases and a posterolateral dissection for anterolateral primaries. For melanoma, Morton NEJM 2014 (MSLT-1) and Faries NEJM 2017 (MSLT-2) established when to biopsy the sentinel node and, once positive, whether completion dissection beats observation (it largely doesn't for survival, though it does improve regional control and provides staging information); we'll dig into these further during the melanoma month. Closer to today, Xu and Sun Front Oncol 2024 looked at 268 patients with parotid-metastatic cutaneous SCCa and found elective neck dissection and elective neck irradiation performed comparably overall, but dissection pulled ahead of irradiation once patients had three or more positive parotid nodes, with observation alone clearly the worst option regardless of nodal burden (retrospective, so treat the exact numbers as hypothesis-generating rather than definitive).

The Basins We Forget

Levels I through VI get all the attention, but parotid, retropharyngeal, and suboccipital nodes matter for specific sites. Gross Arch Otolaryngol Head Neck Surg 2004 established that retropharyngeal nodal involvement carries independent prognostic weight in head and neck SCCa, and Tirelli Head Neck 2022 pooled the more recent literature specifically for oropharyngeal cancer, useful if a staging MRI or PET shows a retropharyngeal node and you're deciding how much it should change the plan. The specific node most of us reference on imaging, the node of Rouviere, was mapped by the French anatomist Henri Rouviere in his 1932 textbook on human lymphatics, decades before anyone was staging it on cross-sectional imaging. We'll come back to lateral neck dissection for thyroid cancer in more detail during the thyroid month, but it's worth remembering now that thyroid cancer's nodal drainage doesn't follow the same rules as mucosal SCCa. A practical pearl worth carrying now: when a thyroid cancer patient has lateral neck disease, it's worth confirming on CT that there isn't a retropharyngeal node hiding alongside it, since that's an easy basin to miss if you're only thinking about levels II through Vb.

Thanks for taking the time to read through this and looking forward to discussing further!

Have a great week!

Rob